长QT综合征
医学
植入式心律转复除颤器
重症监护医学
心脏病
心脏病学
内科学
QT间期
作者
Raquel Neves,Sahej Bains,J. Martijn Bos,Ciorsti MacIntyre,John R. Giudicessi,Michael J. Ackerman
标识
DOI:10.1016/j.tcm.2022.06.006
摘要
Long QT syndrome (LQTS) is a potentially life-threatening, but highly treatable genetic heart disease. LQTS-directed therapies often consist of beta-blockers (BBs), left cardiac sympathetic denervation (LCSD), and/or an implantable cardioverter defibrillator (ICD). However, in clinical practice, many patient-specific and genotype-directed permutations exist. Herein, we aim to review the spectrum of treatment configurations utilized at a single, tertiary center specializing in the care of patients with LQTS to demonstrate optimal LQTS-directed management is not amenable to a "one-size-fits-all" approach but instead benefits from patient- and genotype-tailored strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI